Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

EXEL stock hub

Exelixis, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

EXELis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

12.1B

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

EXEL

In the news

Latest news · EXEL

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E14.6

P25 12.3P50 18.4P75 33.1

Trailing P/E15.9

P25 14.9P50 23.2P75 38.5

ROE41

P25 -105.6P50 -46.5P75 -3.1

ROIC60.4

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All EXEL market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

271

Groups with data

Currency

USD

Showing 271 of 271 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0000939767
Company name	Exelixis, Inc.
Country	United States
Country code	US
Cusip	30161Q104
Employees	1,077
Employees Change	-70%
Employees Change Percent	-6.1
Enterprise value	$10.8B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2000-04-07
Isin	US30161Q1040
Last refreshed	2026-05-10
Market cap	$12.1B
Market cap category	Large-Cap
Price	$48.16
Price currency	USD
Rev Per Employee	2,205,655.52x
Sector	Healthcare
Sic	2836
Symbol	EXEL
Website	https://www.exelixis.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	6.88%
EV Earnings	13.02x
EV Sales Forward	3.99x
EV/EBIT	11.33x
EV/EBITDA	11x
EV/FCF	11.82x
EV/Sales	4.57x
FCF yield	7.58%
Forward P/E	14.64x
P/B ratio	6.31x
P/E ratio	15.93x
P/S ratio	5.1x
PE Ratio10 Y	62.12x
PE Ratio3 Y	26.51x
PE Ratio5 Y	28.94x
PEG ratio	1.33x
PS Forward	4.45x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	40.29%
EBITDA Margin	41.5%
FCF margin	38.63%
Gross margin	96.44%
Gross Profit	$2.3B
Gross Profit Growth	2.98%
Gross Profit Growth Q	10.18%
Gross Profit Growth3 Y	12.6%
Gross Profit Growth5 Y	18.26%
Net Income	$833.4M
Net Income Growth	29.5%
Net Income Growth Q	31.86%
Net Income Growth Quarters	3%
Net Income Growth Years	3%
Net Income Growth3 Y	75.67%
Net Income Growth5 Y	66.69%
Pretax Margin	42.23%
Profit Margin	35.08%
Profit Per Employee	$773,836
Profitable Years	9
ROA	22.03
Roa5y	9.89
ROCE	43.07
ROE	40.99
Roe5y	17.29
ROIC	60.44
Roic5y	29.34

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	25.97%
Cagr15y	10.38%
Cagr1y	30.86%
Cagr20y	7.56%
Cagr3y	35.21%
Cagr5y	13.91%
EPS Growth	37.17
EPS Growth Q	43.64
EPS Growth Quarters	3
EPS Growth Years	3
EPS Growth3 Y	85.92
EPS Growth5 Y	71.26
FCF Growth	11.79%
FCF Growth Q	20.07%
FCF Growth3 Y	51.26%
FCF Growth5 Y	43.37%
OCF Growth	9.74%
OCF Growth Q	19.11%
OCF Growth10 Y	31.39%
OCF Growth3 Y	45.64%
OCF Growth5 Y	36.88%
Revenue Growth	3.33x
Revenue Growth Q	9.97x
Revenue Growth Quarters	3x
Revenue Growth Years	11x
Revenue Growth3 Y	12.6x
Revenue Growth5 Y	18.17x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.87
Assets	$2.6B
Cash	$777.2M
Current Assets	$1.2B
Current Liabilities	$371M
Debt	$169.5M
Debt EBITDA	$0.17
Debt Equity	$0.09
Debt FCF	$0.18
Equity	$1.9B
Liabilities	$657.8M
Long Term Assets	$1.4B
Long Term Liabilities	$286.9M
Net Cash	$1.3B
Net Cash By Market Cap	$10.38
Net Cash Growth	-14.13%
Net Debt EBITDA	$-1.27
Net Debt Equity	$-0.65
Net Debt FCF	$-1.37
Tangible Book Value	$1.9B
Tangible Book Value Per Share	$7.38
WACC	6.28

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.26
Inventory Turnover	3.28
Net Working Capital	$60.5M
Quick ratio	3.01
Working Capital	$837.7M
Working Capital Turnover	$2.59

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	5.19%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	905.43%
1Y total return	30.83%
200-day SMA	41.72
3Y total return	147.23%
50-day SMA	43.5
50-day SMA vs 200-day SMA	50over200
5Y total return	91.8%
All Time High	50.5
All Time High Change	-4.63%
All Time High Date	2000-07-13
All Time Low	1.26
All Time Low Change	3,722.22%
All Time Low Date	2014-12-23
ATR	1.62
Beta	0.38
Beta1y	1.95
Beta2y	0.91
Ch YTD	9.88
High	48.17
High52	49.62
High52 Date	2025-06-23
High52ch	-2.94%
Low	46.46
Low52	33.76
Low52 Date	2025-10-20
Low52ch	42.68%
Ma50ch	10.72%
Premarket Change Percent	-0.15
Premarket Price	$46.14
Premarket Volume	2,504
Price vs 200-day SMA	15.43%
RSI	61.43
RSI Monthly	67.12
RSI Weekly	64.21
Sharpe ratio	0.74x
Sortino ratio	1.27
Total Return	5.19%
Tr YTD	9.88
Tr15y	339.82%
Tr1m	9.48%
Tr1w	10.26%
Tr3m	9.7%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	21
Analyst Count Top	12
Analyst Price Target Top	$46.92
Analyst Ratings	Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$0.74
Earnings EPS Estimate Growth	19.35
Earnings Revenue Estimate	606,406,584x
Earnings Revenue Estimate Growth	9.17x
Operating Income	$957.2M
Operating Income Growth	17.52
Operating Income Growth Q	34.51
Operating Income Growth3 Y	86.71
Operating Income Growth5 Y	78.62
Operating margin	40.29
Price target	$47.25
Price Target Change	$-1.89
Price Target Change Top	$-2.57

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	203,072,463%
Float Percent	80.79%
Shares Insiders	1.92%
Shares Institutions	88.77%
Shares Out	251,355,083
Shares Qo Q	-3.27%
Shares Yo Y	-5.19%
Short Float	13.94%
Short Ratio	11.95
Short Shares	11.26

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$801.6M
Average Volume	2,806,555.95x
Bv Per Share	7.63
CAPEX	$-7M
Ch10y	905.4
Ch15y	339.8
Ch1m	9.48
Ch1w	10.26
Ch1y	30.83
Ch20y	329.2
Ch3m	9.7
Ch3y	147.2
Ch5y	91.8
Ch6m	18.01
Change	4.22%
Change From Open	3.37
Close	46.21
Days Gap	0.82
Depreciation Amortization	28,658,000
Dollar Volume	104,940,447.4
Earnings Date	2026-05-05
Earnings Time	amc
EBIT	$957.2M
EBITDA	$985.8M
EPS	$3.02
F Score	5
FCF	$917.7M
FCF EV Yield	8.46x
FCF Per Share	$3.65
Financing CF	-1,131,882,000
Fiscal Year End	December
Founded	1,994
Goodwill	63,684,000
Graham Number	22.78044
Graham Upside	-52.7
Income Tax	$169.8M
Investing CF	249,607,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-05
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-02-10
Lynch Fair Value	$75.57
Lynch Upside	56.92
Ma150	42.69
Ma150ch	12.82%
Ma20	45.29
Ma20ch	6.34%
Net CF	42,400,000
Next Earnings Date	2026-07-27
Open	46.59
Optionable	Yes
P FCF Ratio	13.19
P OCF Ratio	13.09
Position In Range	99.42
Post Close	48.16
Postmarket Change Percent	-0
Postmarket Price	$48.16
Ppne	95,524,000
Pre Close	46.21
Price Date	2026-05-08
Price EBITDA	$12.28
Ptbv Ratio	6.47
Relative Volume	0.78x
Revenue	2,375,491,000x
SBC By Revenue	4.89x
Share Based Comp	116,103,000
Tax By Revenue	7.15x
Tax Rate	16.92%
Tr20y	329.23%
Tr6m	18.01%
Us State	California
Volume	2,178,996
Z Score	12.52

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does EXEL pay a dividend?

Capital-return profile for this ticker.

Performance

EXEL stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns EXEL?

Insider, institutional, and short-interest positioning.

Institutional ownership

+88.8%

Float: +80.8% of shares outstanding

Insider ownership

+1.9%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

EXEL momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

61.4

Neutral momentum band

Price vs 200-day MA

+15.4%

50/200-day relationship not available

Beta (5Y)

0.38

Less volatile than the market

Sharpe ratio

0.74

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About EXEL

Hub-level FAQ points readers to the deeper analysis pages.

What is the current EXEL stock rating?

Exelixis, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full EXEL analysis?

The full report lives at /stocks/EXEL/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for EXEL?

The latest report frames EXEL around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the EXEL page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.